Abstract:Background: Methylation of CpG islands within the DNA promoter regions is one mechanism that leads to aberrant gene expression in cancer. In particular, the abnormal methylation of CpG islands may silence associated genes. Therefore, using high-throughput microarrays to measure CpG island methylation will lead to better understanding of tumor pathobiology and progression, while revealing potentially new biomarkers. We have examined a recently developed high-throughput technology for measuring genome-wide methylation patterns called mTACL. Here, we propose a computational pipeline for integrating gene expression and CpG island methylation profiles to identify epigenetically regulated genes for a panel of 45 breast cancer cell lines, which is widely used in the Integrative Cancer Biology Program (ICBP). The pipeline (i) reduces the dimensionality of the methylation data, (ii) associates the reduced methylation data with gene expression data, and (iii) ranks methylation-expression associations according to their epigenetic regulation. Dimensionality reduction is performed in two steps: (i) methylation sites are grouped across the genome to identify regions of interest, and (ii) methylation profiles are clustered within each region. Associations between the clustered methylation and the gene expression data sets generate candidate matches within a fixed neighborhood around each gene. Finally, the methylation-expression associations are ranked through a logistic regression, and their significance is quantified through permutation analysis. Results: Our two-step dimensionality reduction compressed 90% of the original data, reducing 137,688 methylation sites to 14,505 clusters. Methylation-expression associations produced 18,312 correspondences, which were used to further analyze epigenetic regulation. Logistic regression was used to identify 58 genes from these correspondences that showed a statistically significant negative correlation between methylation profiles and gene expression in the panel of breast cancer cell lines. Subnetwork enrichment of these genes has identified 35 common regulators with 6 or more predicted markers. In addition to identifying epigenetically regulated genes, we show evidence of differentially expressed methylation patterns between the basal and luminal subtypes. Conclusions: Our results indicate that the proposed computational protocol is a viable platform for identifying epigenetically regulated genes. Our protocol has generated a list of predictors including COL1A2, TOP2A, TFF1, and VAV3, genes whose key roles in epigenetic regulation is documented in the literature. Subnetwork enrichment of these predicted markers further suggests that epigenetic regulation of individual genes occurs in a coordinated fashion and through common regulators.

Multiple Tumor Suppressor Genes Are Concomitantly Methylated In Breast Cancer

Association of Abnormal Methylation of CpG Islands in Promoter Domains of Multiple Tumor Suppressor Genes with Non-Small Cell Lung Cancer

Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer

Circulating Methylated DNA As Biomarkers for Cancer Detection

Methylation profiling of 48 candidate genes in tumor and matched normal tissues from breast cancer patients

Tumor Suppressor Genes Are Frequently Methylated in Lymph Node Metastases of Breast Cancers

Methylation Profiles of 22 Candidate Genes in Breast Cancer Using High-Throughput MALDI-TOF Mass Array

Hypermethylation of Tumor Suppressor Genes Involved in Critical Regulatory Pathways for Developing A Blood-Based Test in Breast Cancer

Differential Methylation Relative to Breast Cancer Subtype and Matched Normal Tissue Reveals Distinct Patterns

Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer

Discovered Key CpG Sites by Analyzing DNA Methylation and Gene Expression in Breast Cancer Samples

Concomitant Hypermethylation of Multiple Genes in Non-Small Cell Lung Cancer (NSCLC)

Methylation of HIN-1, RASSF1A, RIL and CDH13 in Breast Cancer is Associated with Clinical Characteristics, but Only RASSF1A Methylation is Associated with Outcome.

DNA methylation landscapes of 1538 breast cancers reveal a replication-linked clock, epigenomic instability and cis-regulation

Correlation Between CpG Methylation Profiles and Hormone Receptor Status in Breast Cancers.

Global DNA Hypomethylation Coupled to Repressive Chromatin Domain Formation and Gene Silencing in Breast Cancer.

Prediction of epigenetically regulated genes in breast cancer cell lines

Integrated analysis of gene expression and methylation profiles of 48 candidate genes in breast cancer patients

The Methylation Profiles of the Promoter CpG Islands of Nine Tumor Associated Genes Correlate with Their Expressions in Three Lung Cancer Cell Lines

Promoter Methylation Status of PTEN, SYK and Survivin Genes in Breast Cancer Tissues Derived from Chinese Women

Discovering the Key Genes and Important DNA Methylation Regions in Breast Cancer